See more : Sanyang Motor Co., Ltd. (2206.TW) Income Statement Analysis – Financial Results
Complete financial analysis of Star Health and Allied Insurance Company Limited (STARHEALTH.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Star Health and Allied Insurance Company Limited, a leading company in the Insurance – Diversified industry within the Financial Services sector.
- Aygaz A.S. (AYGAZ.IS) Income Statement Analysis – Financial Results
- CJW International CO., LTD. (5301.TWO) Income Statement Analysis – Financial Results
- JPMorgan Global Core Real Assets Limited (JARE.L) Income Statement Analysis – Financial Results
- First Mining Gold Corp. (0P07.L) Income Statement Analysis – Financial Results
- MGC Pharmaceuticals Limited (MXC.L) Income Statement Analysis – Financial Results
Star Health and Allied Insurance Company Limited (STARHEALTH.NS)
About Star Health and Allied Insurance Company Limited
Star Health and Allied Insurance Company Limited provides health insurance products. It offers retail health products to various customer segments, including individuals, families, students, and senior citizens, as well as persons with pre-existing medical conditions across the middle-market customer segment; and group health insurance policies provide to employees of corporates, including SMEs through company health insurance plans. The company also provides personal accident and travel insurance. It distributes its products through individual agents, brokers, corporate agent banks, other corporate agents, and online channel partners comprising web aggregators, as well as directly to customers. As of September 30, 2021, the company had 779 health insurance branches across 25 states and 5 union territories in India. Star Health and Allied Insurance Company Limited was incorporated in 2005 and is based in Chennai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 121.73B | 120.96B | 107.24B | 61.69B | 55.55B | 42.47B | 28.88B | 20.12B | 15.95B | 10.69B | 7.29B | 5.30B |
| Cost of Revenue | -158.80B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 280.53B | 120.96B | 107.24B | 61.69B | 55.55B | 42.47B | 28.88B | 20.12B | 15.95B | 10.69B | 7.29B | 5.30B |
| Gross Profit Ratio | 230.46% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 276.87M | 126.08M | 417.62M | 316.24M | 234.04M | 210.43M | 55.48M | 25.55M | 451.70M | 3.87B | 3.07B | 2.78B |
| Selling & Marketing | 2.00B | 1.47B | 1.34B | 1.36B | 1.30B | 1.34B | 1.09B | 603.83M | 469.28M | 569.97M | 180.75M | 359.08M |
| SG&A | 2.28B | 1.47B | 1.76B | 1.68B | 1.53B | 1.55B | 8.42B | 6.19B | 5.69B | 4.44B | 3.26B | 3.14B |
| Other Expenses | 0.00 | -114.16B | -123.40B | -73.54B | -52.67B | -41.92B | -10.03B | -7.34B | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 144.50B | -112.70B | -121.64B | -71.87B | -51.14B | -40.37B | 10.03B | 7.34B | 14.56B | 12.08B | 8.23B | 6.55B |
| Cost & Expenses | 23.29B | 114.65B | 121.21B | 72.15B | 51.42B | 40.65B | -26.95B | -18.91B | 14.56B | 12.08B | 8.23B | 6.55B |
| Interest Income | 4.71M | 884.19M | 6.30B | 4.20B | 2.87B | 1.95B | 203.21M | 30.09M | 24.20M | 12.11M | 0.00 | 0.00 |
| Interest Expense | 801.39M | 884.19M | 483.84M | 283.66M | 283.97M | 279.76M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 587.07M | 520.67M | 432.99M | 457.30M | 294.40M | 280.93M | 230.82M | 200.82M | -1.41B | 1.37B | 933.24M | 1.26B |
| EBITDA | 12.68B | 9.67B | -13.05B | -9.72B | 4.64B | 2.38B | 2.15B | 1.41B | -40.34M | -30.88M | 4.04B | 0.00 |
| EBITDA Ratio | 10.41% | 6.83% | -13.02% | -15.75% | 8.48% | 5.61% | -0.86% | -0.34% | -0.25% | -0.29% | 0.00% | 0.00% |
| Operating Income | 116.96B | 8.26B | -14.40B | -10.18B | 4.42B | 2.10B | 1.96B | 1.25B | 1.41B | -1.37B | -933.24M | -1.26B |
| Operating Income Ratio | 96.08% | 6.83% | -13.43% | -16.49% | 7.95% | 4.95% | 6.79% | 6.20% | 8.82% | -12.81% | -12.80% | -23.71% |
| Total Other Income/Expenses | -105.67B | -91.20B | -13.97B | -14.46B | 4.21B | -26.12B | -18.75B | -12.75B | -40.34M | -7.65B | 0.00 | 0.00 |
| Income Before Tax | 11.29B | 8.26B | -13.97B | -10.46B | 4.13B | 1.82B | 1.71B | 1.18B | 1.37B | -1.40B | -933.24M | -1.26B |
| Income Before Tax Ratio | 9.27% | 6.83% | -13.02% | -16.95% | 7.44% | 4.29% | 5.93% | 5.86% | 8.56% | -13.10% | -12.80% | -23.71% |
| Income Tax Expense | 2.84B | 2.08B | -3.56B | -2.20B | 1.45B | 540.21M | 10.49M | -269.16M | -40.34M | -30.88M | 0.00 | 0.00 |
| Net Income | 8.45B | 6.19B | -10.41B | -8.26B | 2.68B | 1.28B | 1.70B | 1.18B | 1.37B | -1.40B | -933.24M | -1.26B |
| Net Income Ratio | 6.94% | 5.11% | -9.70% | -13.38% | 4.82% | 3.02% | 5.89% | 5.86% | 8.56% | -13.10% | -12.80% | -23.71% |
| EPS | 14.48 | 10.70 | -18.65 | -16.54 | 5.49 | 2.23 | 3.73 | 2.77 | 3.68 | -4.13 | -2.82 | -4.47 |
| EPS Diluted | 14.19 | 10.41 | -18.65 | -16.54 | 5.38 | 2.23 | 3.73 | 2.77 | 3.68 | -4.13 | -2.82 | -4.47 |
| Weighted Avg Shares Out | 583.39M | 578.36M | 557.98M | 499.19M | 479.39M | 575.52M | 455.58M | 425.99M | 371.13M | 339.11M | 330.93M | 281.02M |
| Weighted Avg Shares Out (Dil) | 595.54M | 594.25M | 557.98M | 499.19M | 489.46M | 575.52M | 455.58M | 425.99M | 370.72M | 339.13M | 331.20M | 281.07M |
Source: https://incomestatements.info
Category: Stock Reports